STAT3 and prostate carcinoma: Indeed, we found that similar to two other STAT3 blockers nimbolide and formononetin previously identified by our group in prostate cancer and multiple myeloma models respectively [17,29], OP-D could also cause a significant increase in ROS (H2O2 specifically).